Active propelled micro robots (MRs) represent a transformative shift in biomedical engineering, engineered to navigate physiological environments by converting chemical, acoustic, or magnetic energy into mechanical propulsion. Unlike passive delivery systems limited by diffusion and systemic clearance, MRs offer autonomous mobility, enabling precise penetration and retention in hard-to-reach tissues. This review provides comprehensive analysis of MR technologies within urology, a field uniquely suited for microrobotic intervention due to the urinary tract’s anatomical accessibility and fluid-filled nature. We explore how MRs address critical therapeutic limitations, including the high recurrence of kidney stones and the rapid washout of intravesical bladder cancer therapies. The review categorizes propulsion mechanisms optimized for the urinary environment, such as urea-fueled nanomotors and magnetic swarms. Furthermore, we detail emerging applications, including bioresorbable acoustic robots for tumor ablation and magnetic grippers for minimally invasive biopsies. Finally, we critically assess the path toward clinical translation, focusing on challenges in biocompatibility, real-time tracking (MRI, MPI, photoacoustic imaging), and the regulatory landscape for these advanced combination products.
Urinary cancers present a severe clinical challenge due to high recurrence rates. Standard intravesical therapies suffer from limited efficacy because of the urinary tract’s robust physiological defenses, namely, the dynamic washout effect during voiding and highly restrictive urothelial barriers, such as the anti-adhesive glycosaminoglycan layer and intercellular tight junctions. This review aims to explore how biomimetic engineering can overcome these obstacles by transitioning drug delivery from passive carriers to active, nature-inspired systems. We conducted a comprehensive review of the recent literature focusing on biomimetic strategies for intravesical drug delivery and urinary cancer theranostics. The analyzed approaches are categorized into chemical biomimicry (such as adhesion and camouflage) and structural/functional biomimicry (including adaptive devices and microrobots). Biomimetic strategies significantly enhance targeted drug retention and tissue penetration. Chemical biomimicry, utilizing mussel-inspired catechol chemistry and cell membrane camouflage, effectively bypasses the urothelial anti-adhesive defenses and reduces the immune clearance. Structural and functional biomimicry, such as naturally derived carriers and actively propelled magnetic or biohybrid microrobots, enables the precise spatial localization and controlled payload release in dynamic fluid environments. Furthermore, lab-on-a-chip technologies and patient-derived organoids (PDOs) offer scalable platforms for screening cargo-specific efficacies and tailoring treatments, providing a crucial bridge to personalized precision medicine. Integrating nature-inspired designs with advanced nanotechnologies provides a highly promising pathway with which to overcome the mechanical and biological barriers of the urinary tract. These biomimetic innovations hold the potential to shift the therapeutic paradigm for urinary oncology, paving the way for more efficient, targeted, and personalized precision medicine.
Therapeutic interventions within the urinary system are often limited by the complex and tortuous anatomy of the renal pelvis and ureters, restricting access to deep regions and increasing the risk of mucosal trauma. In this study, we present a multifunctional, magnetically controlled ferrofluid droplet robotic platform engineered for high deformability and precision navigation. A custom electromagnetic actuation system was developed and optimized via COMSOL Multiphysics (version 6.3, COMSOL Inc., Stockholm, Sweden) simulations to generate programmable magnetic fields. Experimental validation in both simplified environments and anatomically realistic 3D-printed urinary tract models demonstrated the droplets’ capacity for controlled locomotion, reversible deformation, and traversing constrictions significantly smaller than their resting diameter. The droplets’ locomotion and extreme deformability are governed by the dynamic balance between the applied magnetic gradient forces, the restoring interfacial tension of the ferrofluid, and the fluidic viscous drag. Quantitatively, the droplets achieved robust translational velocities up to 260 mm/s under single-coil actuation (51 mT, 20 Hz) and 108 mm/s under a more stable dual-coil configuration (51 mT, 8.3 Hz). Furthermore, two clinically relevant functionalities were successfully executed: rapid vibration-induced release of encapsulated dye for targeted drug delivery, and the precise mechanical capture and transport of artificial kidney stones. These results establish a highly versatile platform for minimally invasive urological procedures, highlighting the immense potential of soft magnetic microrobotics for integrated therapeutic applications.